These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2786645)

  • 1. Practical management of NSAID gastropathy in rheumatic patients.
    Peltier AP
    Scand J Rheumatol Suppl; 1989; 78():12-7; discussion 30-2. PubMed ID: 2786645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and NSAID induced gastropathy.
    Zeidler H
    J Rheumatol Suppl; 1991 Mar; 28():2-5. PubMed ID: 2038013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. There's the forest. The object lesson of NSAID "gastropathy".
    Hadler NM
    J Rheumatol; 1990 Mar; 17(3):280-2. PubMed ID: 2110251
    [No Abstract]   [Full Text] [Related]  

  • 4. Complications of nonsteroidal antiiflammatory drug gastropathy and use of gastric cytoprotection: experience at a tertiary care health center.
    Bakowsky VS; Hanly JG
    J Rheumatol; 1999 Jul; 26(7):1557-63. PubMed ID: 10405945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of NSAID gastropathy.
    Howard JM; Le Riche NG
    Baillieres Clin Rheumatol; 1990 Aug; 4(2):269-91. PubMed ID: 2032300
    [No Abstract]   [Full Text] [Related]  

  • 6. [Development and relapse of gastroduodenal ulcer in patients taking nonsteroid anti-inflammatory drugs: effects of standard risk factors].
    Karateev AE; Nasonova VA
    Ter Arkh; 2008; 80(5):62-6. PubMed ID: 18590118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of clinically manifest ulcers and their complications in patients with rheumatoid arthritis.
    Steen KS; Lems WF; Aertsen J; Bezemer D; Dijkmans BA
    Ann Rheum Dis; 2001 May; 60(5):443-7. PubMed ID: 11302864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NSAID gastropathy: the second most deadly rheumatic disease? Epidemiology and risk appraisal.
    Fries JF
    J Rheumatol Suppl; 1991 Mar; 28():6-10. PubMed ID: 2038014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of NSAIDs-induced gastropathy.
    La Corte R; Caselli M; Ruina M; Bajocchi G; Alvisi V; Trotta F
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():37-41. PubMed ID: 9032582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases.
    Ji KY; Hu FL
    World J Gastroenterol; 2006 Jun; 12(24):3789-92. PubMed ID: 16804960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-steroidal anti-inflammatory drugs induced gastropathy: endoscopic findings in rheumatic patients.
    Rodríguez W; Irrizarry JF; Latimer C
    Bol Asoc Med P R; 1988 Oct; 80(10):366-8. PubMed ID: 3265062
    [No Abstract]   [Full Text] [Related]  

  • 12. [The assessment of the effect of glucocorticosteroid and nonsteroidal anti-inflammatory preparations on the development of an erosive-ulcerative lesion of the gastrointestinal tract in patients with rheumatic diseases].
    Karateev AE; Nasonova VA; Murav'ev IuV
    Ter Arkh; 1999; 71(2):26-30. PubMed ID: 10222549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Importance of age and other risk factors in NSAID-induced gastropathy].
    Lee HL; Han DS; Kim JB; Kim JP; Jeon YC; Sohn JH; Hahm JS
    Korean J Gastroenterol; 2004 Nov; 44(5):246-51. PubMed ID: 15564803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From peptic ulcer disease to NSAID gastropathy. An evolving nosology.
    Roth SH
    Drugs Aging; 1995 May; 6(5):358-67. PubMed ID: 7647425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroprotective agents for the prevention of NSAID-induced gastropathy.
    Ares JJ; Outt PE
    Curr Pharm Des; 1998 Feb; 4(1):17-36. PubMed ID: 10197031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NSAIDs: new approaches to limiting gastropathy.
    Zeidler H; Münzel P
    Scand J Rheumatol Suppl; 1989; 78():18-23; discussion 30-2. PubMed ID: 2525273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The endoscopic assessment of the effect of ranitidine and pirenzepine on the manifestations of the gastropathy induced by nonsteroidal anti-inflammatory preparations].
    Karateev AE; Murav'ev IuV; Nasonova VA
    Ter Arkh; 1997; 69(5):67-9. PubMed ID: 9235663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymptomatic and symptomatic gastroduodenal patients affected by rheumatic disease treated with non-steroidal anti-inflammatory drugs.
    Magarò M; Altomonte L; Zoli A; Mirone L; Berchicci MC; Tricerri A; Corvino G
    Panminerva Med; 1989; 31(1):16-8. PubMed ID: 2786181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?
    Adebayo D; Bjarnason I
    Postgrad Med J; 2006 Mar; 82(965):186-91. PubMed ID: 16517800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [NSAID-gastropathy: state-of-the-art therapy optimization capabilities in outpatient practice].
    Burkov SG; Arutiunov AT; Gurova NIu; Lobanova EG; Nikiforov PA; Okoemov MN; Cherezova IN; Chugunnikova LI
    Eksp Klin Gastroenterol; 2008; (3):97-101. PubMed ID: 19145889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.